MiLaboratories Revenue and Competitors
Estimated Revenue & Valuation
- MiLaboratories's estimated annual revenue is currently $3.4M per year.
- MiLaboratories's estimated revenue per employee is $155,000
Employee Data
- MiLaboratories has 22 Employees.
- MiLaboratories grew their employee count by 22% last year.
MiLaboratories's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Bioinformatics Support | Reveal Email/Phone |
2 | Lead Bioinformatics Scientist | Reveal Email/Phone |
MiLaboratories Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is MiLaboratories?
MiLaboratories is a technology leader in profiling of mammalian adaptive immune system. Over the last decade, we developed an original UMI technology for molecular barcoding and a suite of algorithms and software tools for generation and analysis of deep and representative repertoire of T-cell and B-cell receptors. We offer TCR and BCR library construction kits, best in class software and bumper-to-bumper services, wet lab and analytics. Our flagship suite, MiXCR, is a gold standard in immunosequencing and is applied by a number of global pharmaceutical companies, leading academic groups and sequencing hardware companies.
keywords:N/AN/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.2M | 26 | 63% | N/A |
#2 | $5.9M | 26 | -7% | N/A |
#3 | $3.2M | 28 | N/A | N/A |
#4 | $4.8M | 29 | 4% | N/A |
#5 | $5.7M | 30 | 0% | $24.1M |